• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨曲南在儿科的临床研究

[Clinical study on aztreonam in pediatrics].

作者信息

Niino M, Kida K, Matsuda H, Murase M

出版信息

Jpn J Antibiot. 1985 Nov;38(11):3334-42.

PMID:4094066
Abstract

Efficacy and safety of aztreonam (AZT) for 31 cases of infections of children were studied with the following results. Clinical efficacy of AZT for 22 respiratory tract infections, 5 urinary tract infections and 2 gastrointestinal infections was "excellent" for 19 cases (65.5%), "good" for 9 cases (31.0%) and "poor" for 1 case (3.4%) with an overall effective rate of 96.6%. Microbiological effect of AZT for 19 isolated strains (15 cases) was 100% in disappearance of the Gram-negative bacteria and 89.5% on the whole. With regard to side effect of AZT in 31 cases, there was a slight elevation of GPT in 1 case and eosinophilia in 2 cases. It was considered from the above results that AZT is a useful and safe antibiotic for infections of children.

摘要

对31例儿童感染患者使用氨曲南(AZT)进行疗效和安全性研究,结果如下。AZT用于22例呼吸道感染、5例尿路感染和2例胃肠道感染,临床疗效为“优”19例(65.5%),“良”9例(31.0%),“差”1例(3.4%),总有效率为96.6%。AZT对19株分离菌株(15例)的微生物学效果为革兰阴性菌消失率达100%,总体达89.5%。31例患者使用AZT的副作用方面,1例谷丙转氨酶轻度升高,2例嗜酸性粒细胞增多。从上述结果来看,AZT是治疗儿童感染的一种有效且安全的抗生素。

相似文献

1
[Clinical study on aztreonam in pediatrics].氨曲南在儿科的临床研究
Jpn J Antibiot. 1985 Nov;38(11):3334-42.
2
[Clinical experience with aztreonam in the pediatric field].[氨曲南在儿科领域的临床经验]
Jpn J Antibiot. 1985 Nov;38(11):3316-22.
3
[Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
Hinyokika Kiyo. 1989 Apr;35(4):711-6.
4
[Clinical study of aztreonam on respiratory tract infections caused by gram-negative pathogens].氨曲南治疗革兰阴性病原菌所致呼吸道感染的临床研究
Jpn J Antibiot. 1985 Nov;38(11):3415-33.
5
[Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
Jpn J Antibiot. 1985 Nov;38(11):3195-216.
6
[Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].氨曲南在新生儿和早产儿中的药代动力学及临床研究(首次报告)。氨曲南单药治疗的有效性和安全性研究。围产期联合研究组对氨曲南的一项研究
Jpn J Antibiot. 1990 Mar;43(3):543-62.
7
[Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].氨曲南(AZT)治疗复杂性尿路感染的临床评估
Hinyokika Kiyo. 1989 Dec;35(12):2155-61.
8
[Fundamental and clinical studies on aztreonam in the pediatric field].[氨曲南在儿科领域的基础与临床研究]
Jpn J Antibiot. 1985 Nov;38(11):3273-84.
9
[Pharmacokinetics and clinical evaluations on aztreonam in perinatal infections in obstetrics and gynecology. A study of aztreonam in the perinatal co-research group].氨曲南在妇产科围产期感染中的药代动力学及临床评价。围产期联合研究组对氨曲南的一项研究
Jpn J Antibiot. 1990 Apr;43(4):736-53.
10
[Fundamental and clinical studies of aztreonam in the field of pediatric].氨曲南在儿科领域的基础与临床研究
Jpn J Antibiot. 1985 Nov;38(11):3239-62.